483
Allergan Sales, LLCFDA 483 - Allergan Sales, LLC - February 27, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Allergan Sales, LLC in Waco, TX, a sterile drug manufacturer, revealed three significant observations. The firm was cited for inadequate procedures to prevent microbiological contamination, deficiencies in environmental monitoring systems, and issues with cleaning and disinfection protocols in aseptic processing areas. These findings indicate potential risks to the sterility of drug products.
Open in Dashboard
ID · 209b505c-c846-4bd9-acbb-c413676c87f2